Wordt geladen...
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
OBJECTIVE: To assess the effect of anti-CD20 B-cell depletion with rituximab (RTX) on relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD). METHODS: Retrospective review of RTX-treated MOGAD patients from 29 centres in 13 countries. The primary outcome measure wa...
Bewaard in:
Gepubliceerd in: | Mult Scler Relat Disord |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2020
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7895306/ https://ncbi.nlm.nih.gov/pubmed/32629363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102251 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|